Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women with PCOS who have vitamin D deficiency (serum 25-hydroxyvitamin D\<20 ng/mL)~Exclusion Criteria:~* Pregnant, postpartum, breast feeding~* Taking Metformin, vitamin D, or any hormonal therapy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: f

Study Arms:
- Vitamin D3 (Type: ACTIVE_COMPARATOR): Women allocated to vitamin D3 group received one capsule 50.000 IU of vitamin D3 once weekly for eight weeks.
- Placebo (Type: PLACEBO_COMPARATOR): Women in the placebo group received once capsule of placebo once weekly for eight weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).